LncRNAs | Disease | Experimental methods | Regulated | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Pubmed ID | Year |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WDFY3-AS2 | lung adenocarcinoma | qPCR, Western blot, Luciferase reporter assay, RIP etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32275336 | |
WDFY3-AS2 | esophageal cancer | RNA-seq | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | 30972633 | |
WDFY3-AS2 | breast cancer | qPCR | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 30959550 | |
WDFY3-AS2 | ovarian cancer | qPCR, Western blot, Luciferase reporter assay, RIP | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31347170 | |
WDFY3-AS2 | hepatocellular carcinoma | qPCR, RNAi, Cell proliferation assay, Cell migration assay etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 28194035 |